Not all samples tell the same story. New data from the #TAXIS study show genomic tests on lymph nodes may misclassify breast cancer risk in 1 out of 6 cases. Primary tumour remains the gold standard.
#BreastCancer #GenomicTesting #TAXISstudy #ClinicalResearch
#BreastCancer #GenomicTesting #TAXISstudy #ClinicalResearch
New findings from TAXIS study | Department of Clinical Research | University of Basel
Sub-study: Genomic tests are more reliable from primary tumour tissue than from lymph nodes.
dkf.unibas.ch
July 15, 2025 at 8:44 AM
Not all samples tell the same story. New data from the #TAXIS study show genomic tests on lymph nodes may misclassify breast cancer risk in 1 out of 6 cases. Primary tumour remains the gold standard.
#BreastCancer #GenomicTesting #TAXISstudy #ClinicalResearch
#BreastCancer #GenomicTesting #TAXISstudy #ClinicalResearch